Actively Recruiting
Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section
Led by Aretaieion University Hospital · Updated on 2025-07-22
60
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections
CONDITIONS
Official Title
Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult parturients, ASA physical status I-II
- Singleton pregnancy beyond 37 weeks of gestation
- Scheduled for elective cesarean section
You will not qualify if you...
- ASA physical status higher than III
- Age under 18 years
- Singleton pregnancy under 37 weeks of gestation
- Body mass index over 40 kg/m2
- Body weight less than 50 kg
- Body weight more than 100 kg
- Height less than 150 cm
- Height more than 180 cm
- Multiple pregnancies
- Emergency delivery
- Fetal abnormalities
- Fetal distress
- Pregnancy-related conditions such as preeclampsia, eclampsia, premature labor, or placental problems
- Pregnancy-related diseases including hepatic failure, pseudocholinesterase deficiency, or neuromuscular disorders
- Lack of informed consent
- Contraindications to regional anesthesia such as low platelet count, blood clotting problems, or allergy to local anesthetics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aretaieion University Hospital
Athens, Greece, 11528
Actively Recruiting
Research Team
K
Kassiani Theodoraki, PhD, DESA
CONTACT
M
Marianna Mavromati, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here